Codex DNA Inc. (DNAY)
NASDAQ: DNAY
· Real-Time Price · USD
1.30
0.10 (8.33%)
At close: Jan 04, 2023, 6:00 AM
Codex DNA Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 1.57M | 1.55M | 5.56M | 8.65M | 6.32M | 9.47M | 6.67M | 5.66M | 5.64M | 3.08M | 2.79M | 2.85M | 2.33M |
Cost of Revenue | 557K | 2.35M | 2.57M | 2.96M | 2.81M | 3.02M | 3.02M | 2.94M | 2.86M | 2.2M | 1.62M | 1.9M | 1.02M |
Gross Profit | 1.01M | -799K | 3M | 5.69M | 3.51M | 6.45M | 3.66M | 2.71M | 2.78M | 882K | 1.16M | 953K | 1.3M |
Operating Income | -5.48M | -11.49M | -10.12M | -7.97M | -11.37M | -10.35M | -11.25M | -14.53M | -12.85M | -14.86M | -9.44M | -7.57M | -6.26M |
Interest Income | 78K | 160K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -6.18M | -11.56M | -10.62M | -8.28M | -11.12M | -8.13M | -12.31M | -14.82M | -13.19M | -12.49M | -9.82M | -9.2M | -7.44M |
Net Income | -7.26M | -13.18M | -11.2M | -8.44M | -11.11M | -8.08M | -12.31M | -14.83M | -13.19M | -12.49M | -9.82M | -9.2M | -7.44M |
Selling & General & Admin | 3.98M | 7.21M | 9M | 9.07M | 9.36M | 10.19M | 9.09M | 10.07M | 9.26M | 7.65M | 7.01M | 5.78M | 4.69M |
Research & Development | 2.17M | 2.47M | 4.12M | 4.59M | 5.12M | 4.14M | 5.82M | 7.12M | 6.38M | 5.33M | 3.59M | 2.75M | 2.88M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 6.15M | 9.68M | 13.12M | 13.66M | 14.48M | 14.33M | 14.91M | 17.2M | 15.64M | 12.98M | 10.6M | 8.53M | 7.57M |
Interest Expense | -219K | -214K | -683K | -333K | -249K | -2.17M | 319K | 299K | 336K | -2.37M | 381K | 379K | 241K |
Selling & Marketing Expenses | 880K | 1.7M | 2.74M | 3.36M | 3.81M | 4.68M | 3.83M | 4.51M | 3.46M | 3.04M | 2.96M | 2.63M | 2.27M |
Cost & Expenses | 6.71M | 12.02M | 15.69M | 16.62M | 17.29M | 17.35M | 17.93M | 20.14M | 18.5M | 15.18M | 12.23M | 10.42M | 8.59M |
Income Tax Expense | -1K | -1K | -14K | -4K | -3K | -42K | 6K | 6K | 6K | 4K | 4K | 2K | 4K |
Shares Outstanding (Basic) | 17.73M | 17.3M | 29.95M | 29.77M | 29.66M | 29.46M | 29.52M | 29.44M | 29.33M | 29.3M | 29.3M | 25.4M | 21.51M |
Shares Outstanding (Diluted) | 17.73M | 17.3M | 29.95M | 29.77M | 29.66M | 29.46M | 29.52M | 29.44M | 29.33M | 29.3M | 29.3M | 25.4M | 21.51M |
EPS (Basic) | -0.41 | -0.76 | -0.37 | -0.28 | -0.37 | -0.27 | -0.42 | -0.5 | -0.45 | -0.43 | -0.34 | -0.36 | -0.35 |
EPS (Diluted) | -0.41 | -0.76 | -0.37 | -0.28 | -0.37 | -0.27 | -0.42 | -0.5 | -0.45 | -0.43 | -0.34 | -0.36 | -0.35 |
EBITDA | -5.48M | -11.49M | -10.12M | -7.97M | -10.97M | -11.59M | -11.99M | -13.88M | -12.26M | -15.05M | -9.07M | -8.45M | -6.84M |
EBIT | n/a | n/a | -11.3M | -8.62M | -10.96M | -7.84M | -11.99M | -14.53M | -12.85M | -14.86M | -9.44M | -8.82M | -7.2M |
Depreciation & Amortization | n/a | n/a | -39.59K | 122.08K | 400K | -1.24M | -738K | 647K | 593K | -191K | 370K | 370K | 359K |